TomoTherapy well accepted in Asia Pacific

SUNNYVALE, California, USA -- Radiation oncology company, Accuray Incorporated, showcased new clinical research on its TomoTherapy System at a users’ meeting held in conjunction with the Hong Kong Sanatorium & Hospital Scientific Meeting on Radiotherapy and TomoTherapy on September 21-23, 2012 in Hong Kong. The conference brought together approximately 130 users from across Asia Pacific for three days of education on the growing body of clinical evidence supporting the use of the TomoTherapy System for a wide range of clinical indications.

"I was thrilled by the breadth and depth of knowledge shared between peers on the use of the TomoTherapy System as well as the sustained advancement of the technology – allowing us to provide the most optimal treatments to more patients," said Dr Daniel Chua Tsin-Tien, associate director of Comprehensive Oncology Center of Hong Kong Sanatorium & Hospital, who chaired the 2012 TomoTherapy Asia Pacific Users' Meeting.

According to the TomoTherapy website, conventional machine design allows radiation to be delivered from only a few directions, whereas the TomoTherapy treatment system’s linear accelerator (linac) is mounted to a CT scanner-like ring gantry, which means treatments can be delivered continuously, from all angles around the patient. More beam directions give physicians more control in how they plan treatments—and more assurance that dose will be confined to the tumor, reducing the risk of short- and long-term side effects.

Substantial clinical experience on the TomoTherapy System was also shared by leading hospitals in the region. This involved collaborative review and development of optimal treatment plans for four selected challenging clinical situations contributed from across the region.

The participation of attendees from multiple countries in Asia Pacific underscores the continued momentum for the system and further supports increased adoption throughout the region, said Bob Wong, managing director of Accuray Asia Pacific Region. "Over the past year, Accuray's business success has been bolstered by the joint effort with our partners in Asia Pacific and this June marked the one year anniversary of our acquisition of TomoTherapy Incorporated. We are proud of what we have accomplished to date, and most importantly reaffirm our commitment to not only achieving, but surpassing our users' expectations and goals."

Highlights of the Users' Meeting included an opening presentation by Dr Kwan Wing-Hong on the role of radiation therapy and TomoHelical in treating nasopharyngeal carcinoma and breast cancer patients at the Hong Kong Sanatorium & Hospital.

Dr. Paul W. Read,Air Jordan IV 4 Shoes